Navigation Links
Damon Runyon and Doris Duke Foundations announce partnership to support physician-scientists
Date:7/1/2010

New York, NY, July 1, 2010 The Damon Runyon Cancer Research Foundation (DRCRF) and the Doris Duke Charitable Foundation (DDCF) are pleased to announce their partnership in supporting an early career physician-scientist. Tobias J.E. Carling, MD, PhD, Assistant Professor of Surgery at the Yale University School of Medicine has been named as the first Doris Duke-Damon Runyon Clinical Investigator.

Dr. Carling will receive a total of $486,000 over three years for his project "Molecular Genetics of Endocrine Tumor Disease" (see below for lay summary). In addition, DRCRF will retire up to $100,000 of any qualifying outstanding medical school debt still owed by Dr. Carling.

It is a great honor to receive the Doris Duke-Damon Runyon Clinical Investigator Award for my research and scientific career development and to be supported by two of the most prestigious private medical research foundations in the country, said Dr. Carling.

The Damon Runyon and Doris Duke Foundations support young physician-scientists through similar grant programs, the Clinical Investigator Award and Clinical Scientist Development Award, respectively. Dr. Carling was recommended to receive each of these awards following rigorous independent peer review processes by both Foundations.

"There is a significant shortage of talented physician-scientists dedicated to translating research from the laboratory to the patient's bedside in search of breakthrough treatments," said Lorraine Egan, Executive Director of the Damon Runyon Cancer Research Foundation. "Both Foundations are highly committed to encouraging the careers of these unique individuals."

"We're delighted to be partnering with the Damon Runyon Cancer Research Foundation to fund Dr. Carling's project," said Ed Henry, president of the Doris Duke Charitable Foundation. "This award allows Dr. Carling the financial and professional benefits of being affiliated with both DDCF and DRCRF."

Lay Summary of Research

Dr. Carling focuses on endocrine tumors, a type of cancer which affects hormone-producing tissues in the body (such as the thyroid, pituitary gland, adrenal gland and islet cells of the pancreas). The underlying genetic basis for endocrine tumors is not yet known. Dr. Carling's goal is to complete a comprehensive genomic analysis of patients with endocrine tumor disease in order to identify individual genes involved in early cancer formation. His research will provide important insights into the development of endocrine tumors as well as other cancer types, laying the basis for future individualized medical and surgical management of cancer.

Dr. Carling works under the mentorship of Richard P. Lifton, MD, PhD, and Robert Udelsman, MD, MBA.


'/>"/>

Contact: Yung S. Lie, PhD
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Related medicine news :

1. Three Pioneering Ideas in Cancer Research Granted Prestigious Damon Runyon-Rachleff Innovation Awards
2. Crown Works Dental Laboratory hosts CE Course by Dr. Damon C. Adams, Editor -In -Chief of Dentistry Today
3. Damon Runyon Cancer Research Foundation awards $3.1M to 8 top young clinical investigators
4. Now Live! The “Safe Handling Dance” Video to Benefit ASHP/ONS Foundations
5. Drug Information Association (DIA) Announces New Clinical Safety and Pharmacovigilance Certificate Program
6. Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange
7. Pluromed Announces Completion of Enrollment in LeGoo™ Cardiac Bypass Clinical Trial
8. New Speakers Announced for the 2010 Personalized Medicine Partnerships Conference
9. Nuvo Research announces early redemption of 5% convertible debentures
10. Royal Caribbean International and LimoRes.com Announce Exclusive Partnership
11. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Anxiety of older Americans over ... of Medicare Part D a decade ago, according to The Senior Citizens League ... on how they are coping with rapidly rising costs. “The implications are chilling, ...
(Date:2/10/2016)... ... February 09, 2016 , ... According to a recent ... dramatic increase in the number of patients under the age of 30. According to ... seeing in their offices, and may indicate an overall shift in the rapidly growing ...
(Date:2/9/2016)... Nevada (PRWEB) , ... February 09, 2016 , ... ... providing treatment to Medicaid beneficiaries who are diagnosed with autism spectrum disorder (ASD). ... Nevada. Autism treatment using applied behavior analysis (ABA) is key to providing ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... compensation fee schedule rates and Medicare rates for a variety of medical services ... report, Evaluation of the 2015 Fee Schedule Rates in Illinois, are ...
(Date:2/9/2016)... NY (PRWEB) , ... February 09, 2016 , ... Establishment ... appointment of Dr. David Hung to the company´s Board of Directors. , ... world class scientist and an exceptional entrepreneur.” said Juan Jose Chacon Quiros, CEO of ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016  Increasingly, health care professionals are enhancing patient ... wireless technology. With the Vios Monitoring System from Vios ... remotely detect problems before they become serious by continuously ... the United States . ... --> The Vios Monitoring System connects ...
(Date:2/9/2016)... Feb. 9, 2016  Johnson & Johnson (NYSE: ... Global Healthcare Conference on Tuesday, Feb. 23, at the ... Caruso , Vice President, Finance & Chief Financial Officer ... represent the Company in a session scheduled at 10:00 ... --> www.investor.jnj.com . --> This webcast ...
(Date:2/9/2016)... , Feb. 9, 2016 Athenex, Inc. announced ... as Vice President of Corporate Strategy and Business Development based ... MBA has joined as Senior Director and Deputy Head of Clinical Research ... . Simon Pedder stated, "Athenex has a ... a while. Coupled together with their unique business model and ...
Breaking Medicine Technology: